Cargando…

Risk factors for drug-treated major adverse cardio-cerebrovascular events in patients on primary preventive statin therapy: A retrospective cohort study

We aim to identify risk factors of major adverse cardio-cerebrovascular events (MACCE) using a proxy of drug treatment for a MACCE after the start of statin therapy in the primary cardiovascular prevention group, taking drug dose, persistency and adherence into account. We conducted a retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steenhuis, Dennis, de Vos, Stijn, Bos, Jens H.J., Hak, Eelko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244680/ https://www.ncbi.nlm.nih.gov/pubmed/37292425 http://dx.doi.org/10.1016/j.pmedr.2023.102258

Ejemplares similares

Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study
por: Steenhuis, Dennis, et al.
Publicado: (2022)

Targeting the Beta-2-Adrenergic Receptor and the Risk of Developing Alzheimer’s Disease: A Retrospective Inception Cohort Study
por: Hutten, Danique R., et al.
Publicado: (2022)

Sex disparities in the effect of statins on lipid parameters: The PharmLines Initiative
por: Hunt, Nicholas B., et al.
Publicado: (2022)

Low TLR7 gene expression in atherosclerotic plaques is associated with major adverse cardio- and cerebrovascular events
por: Karadimou, Glykeria, et al.
Publicado: (2017)

Identification of potentially inappropriate medications with risk of major adverse cardio- and cerebrovascular events among elderly patients
por: Lima, Joana C. F., et al.
Publicado: (2021)

Efficacy of Standard and Intensive Statin Treatment for the Secondary Prevention of Cardiovascular and Cerebrovascular Events in Diabetes Patients: A Meta-Analysis
por: de Vries, Folgerdiena M., et al.
Publicado: (2014)

Atrial high-rate episodes predict major adverse cardio/cerebrovascular events in patients with cardiac implantable electrical devices
por: Chen, Ju-Yi, et al.
Publicado: (2021)

Association between statins and infections among patients with diabetes: a cohort and prescription sequence symmetry analysis
por: Pouwels, Koen B., et al.
Publicado: (2016)

Impact of statin intensity on adverse cardiac and cerebrovascular events in older adult patients with myocardial infarction
por: Moon, In Tae, et al.
Publicado: (2021)

The effect of adherence to statin therapy on cardiovascular mortality: quantification of unmeasured bias using falsification end-points
por: Bijlsma, Maarten J., et al.
Publicado: (2016)

Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis
por: Zhong, Ping, et al.
Publicado: (2017)

Cerebrovascular Disease and Statins
por: Beltrán Romero, Luis M., et al.
Publicado: (2021)

Low miR‐19b‐1‐5p Expression Is Related to Aspirin Resistance and Major Adverse Cardio‐ Cerebrovascular Events in Patients With Acute Coronary Syndrome
por: Singh, Sandeep, et al.
Publicado: (2021)

Comparing different types of statins for secondary prevention of cardio-cerebrovascular disease from a national cohort study
por: Kim, Joungyoun, et al.
Publicado: (2021)

Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes
por: Fan, Dabei, et al.
Publicado: (2018)

The Impact of Aging on Cardio and Cerebrovascular Diseases
por: Izzo, Carmine, et al.
Publicado: (2018)

Prevalence and trends of perioperative major adverse cardiovascular and cerebrovascular events during cancer surgeries
por: Ramamoorthy, Venkataraghavan, et al.
Publicado: (2023)

Does Statin Therapy Reduce the Risks of Mortality and Major Adverse Cardiac and Cerebrovascular Events in Young Adults with End-Stage Renal Disease? Population-Based Cohort Study
por: Cheng, Ya-Lien, et al.
Publicado: (2021)

Patient-Level Prediction of Cardio-Cerebrovascular Events in Hypertension Using Nationwide Claims Data
por: Park, Jaram, et al.
Publicado: (2019)

Hepatic FDG uptake in patients with NAFLD: An important prognostic factor for cardio-cerebrovascular events?
por: Dimitriu-Leen, Aukelien C., et al.
Publicado: (2016)

Soluble fibrin monomer complex is associated with cardio- and cerebrovascular events in patients with heart failure
por: Yoshihisa, Akiomi, et al.
Publicado: (2020)

Novel Drugs Development for Cardio-/Cerebrovascular Diseases
por: Sheu, Joen-Rong, et al.
Publicado: (2014)

Cytokines as therapeutic targets for cardio- and cerebrovascular diseases
por: Liberale, Luca, et al.
Publicado: (2021)

Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome
por: Baluja, Aurora, et al.
Publicado: (2019)

Major Adverse Cardiac and Cerebrovascular Events in Patients Undergoing Simultaneous Heart Surgery and Carotid Endarterectomy
por: Gerfer, Stephen, et al.
Publicado: (2023)

Identification of major cardiovascular events in patients with diabetes using primary care data
por: Pouwels, Koen Bernardus, et al.
Publicado: (2016)

Risk of neuropsychiatric adverse events associated with varenicline treatment for smoking cessation among Dutch population: A sequence symmetry analysis
por: Wang, Yuanyuan, et al.
Publicado: (2021)

Discontinuation and dose adjustment of metoprolol after metoprolol‐paroxetine/fluoxetine co‐prescription in Dutch elderly
por: Bahar, Muh. Akbar, et al.
Publicado: (2018)

Cardio‐ankle vascular index as a predictor of major adverse cardiovascular events in metabolic syndrome patients
por: Limpijankit, Thosaphol, et al.
Publicado: (2021)

Storax, A Promising Botanical Medicine for Treating Cardio-Cerebrovascular Diseases: A Review
por: Xu, Zhuo, et al.
Publicado: (2021)

Effect of brachial-ankle pulse wave velocity combined with blood pressure on cardio-cerebrovascular events
por: Wu, Yuntao, et al.
Publicado: (2019)

Elevated levels of adiponectin associated with major adverse cardiovascular and cerebrovascular events and mortality risk in ischemic stroke
por: Tu, Wen-Jun, et al.
Publicado: (2020)

Long‐Term Blood Pressure Variability and Major Adverse Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage
por: Castello, Juan Pablo, et al.
Publicado: (2022)

Major Adverse Cardiac and Cerebrovascular Events in Geriatric Patients with Obstructive Sleep Apnea: An Inpatient Sample Analysis
por: Desai, Rupak, et al.
Publicado: (2023)

Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events: a population-based retrospective inception cohort study in the Netherlands
por: Li, Xuechun, et al.
Publicado: (2023)

Ferroptosis: New Dawn for Overcoming the Cardio-Cerebrovascular Diseases
por: Luo, Meng-Yi, et al.
Publicado: (2021)

Creation and Validation of an EMR-based Algorithm for Identifying Major Adverse Cardiac Events while on Statins
por: Wei, Wei-Qi, et al.
Publicado: (2014)

Cardio-cerebrovascular complications in COVID-19 patients: A retrospective cohort study
por: Hong, Kwan, et al.
Publicado: (2022)

Atrial Fibrillation as a Risk Factor for Major Adverse Cardiac and Cerebrovascular Events after Non-cardiac Surgery
por: Shin, Dong Geum, et al.
Publicado: (2020)

Development and Validation of a Nomogram of In-hospital Major Adverse Cardiovascular and Cerebrovascular Events in Patients With Acute Coronary Syndrome
por: Bo, Xiangwei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k2rhctdtphtqom53tjmhirtr9a